Most visited

1 month ago
Novavax, Inc. (NASDAQ: NVAX) is among the companies developing a coronavirus vaccine, and unlike the frontrunners that have advanced their respective vaccine candidates into Phase 3 trials, Novavax is still in Phase 2. Despite trailing the frontrunners, Novavax has been assiduously stitching up manufacturing

0o

48%
Menu

Leave a Comment